Efficacy of oral meloxicam in analgesia after cesarean section

Comparison of the efficacy of oral meloxicam with paracetamol and sufentanil pain pump in analgesia after cesarean section

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180206038648N1

Enrollment

Registered

2018-02-23

Start date

2017-06-26

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section. Delivery by caesarean section, unspecified

Interventions

Intervention 1: Intervention group: administration of the meloxicam tablet (Hexal, Germany) orally at a dose of 7.5 mg two times before the onset of the spinal anesthesia and 12 hours later. Intervent

Eligibility

Sex/Gender

Female

Age

18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Elective cesarean section Term pregnancy ASA Class I & II

Exclusion criteria

Exclusion criteria: Drug abuse Bleeding disorders Severe psychiatric disorders Body mass index higher than 35 Preeclampsia

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: 6,12, and 24 hours after surgery. Method of measurement: VAS (Vision Scale).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaman Nasrollahi

Zahedan University of Medical Sciences

dr.nasrollahi@zaums.ac.ir+98 54 3329 5570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026